26 May 2013
Keywords: gsk, results, line, company, guidance, shares, fall
Article | 23 February 2004
UK pharmaceutical major GlaxoSmithKline has forecast flat earnings for 2004, as generic competition to its top three drugs eats into revenues.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2004
24 May 2013
© 2013 thepharmaletter.com